OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

FIND Trial: ctDNA-Guided Surveillance After Curative-Intent Colorectal Cancer Surgery

Jay Bhattacharya Announces New U.S. Government Policy on High-Risk Life Sciences Research

OncoDaily Lived Experience Advocacy Hub

Fake Sterling Silver on TikTok Shop: The Alarming Cadmium and the Cancer Risk

The Hidden Burden of Cancer Hospitalization

Oncology News, Insights, Stories by OncoDaily

Evis Sala
Voices

Evis Sala: Historic Establishment of Albania’s First National Cancer Institute

Claudin 18.2
Gastrointestinal Oncology

Claudin 18.2 and FGFR2b: New Biomarkers in Gastric and Esophageal Cancer

Pramesh CS
Voices

Pramesh CS: Every Great Research Career Has a Defining Moment. CReDO Could Be Yours

Top 10 GU Oncology Updates – July 2026

Patrick Soon-Shiong: So Excited That UAE EDE Took the Lead to Authorize the Broadest Aproval for ANKTIVA

Andrea Necchi: Our First Network Meta-Analysis of Perioperative Trials in MIBC

Bishal Gyawali։ New Episode of Grounded in Groundshot Podcast With Chris Booth

Enfortumab Vedotin–Pembrolizumab Improves Survival in Cisplatin-Eligible Bladder Cancer

ESO Opens Applications for the 2nd Cohort of the Certificate of Advanced Studies in Thoracic Malignancies

EUPATI Patient Expert Training Programme on Medicines’ Research and Development

Voices
Muna Al-Khaifi

Muna Al-Khaifi Explores How Exercise Improves Outcomes in Breast Cancer

Lillian Siu: Investing in the Next Generation of Cancer Research Leaders Through the Philadelphia Cycling Classic – AACR Charity Ride

Nicholas Sarlis: 2nd Annual Global Cancer Research and Innovation Symposium

Amy C. Moore։ World Lung Cancer Day Awareness Initiative With The White Ribbon Project

Oana Voicu: From a Medical Student to Presenting a Case on Prostate Cancer at ESMO 2026

Brian Shkabari: How the FDA Cancer Drug Approval Landscape Has Shifted Over Two Decades

Norman Ng: Four Key Priorities for Hong Kong’s Refreshed Cancer Strategy

FDA Approvals
FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

OncoDaily 100
100 influential survivors

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

AACR Special Conference in Cancer Research: Cancer Biology-informed Radioligand Therapy

American Association for Cancer Research (AACR)

07 Jan
Radioligand Therapy

SIOP-NEXT 2026: From Insight to Impact

International Society of Paediatric Oncology (SIOP)

14 Sep
SIOP-NEXT

The 2nd Annual GCRIS 2026

Association of Value-Based Cancer Care (AVBCC)

05 Oct
Nicholas Sarlis

2026 Pacific Northwest Head and Neck Cancer Symposium

Fred Hutch Cancer Center

10 Oct
Head and Neck Cancer Symposium

Best of ASCO - Taipei 2026

Horizon CME

04 Sep
Best of ASCO

Immune-oncology
Predicting Immunotherapy Response Beyond PD-L1 and Tumor Mutational Burden

Predicting Immunotherapy Response Beyond PD-L1 and Tumor Mutational Burden

Perioperative Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Artificial Intelligence in Cancer Immunotherapy

Can ctDNA Predict Both Benefit and Toxicity From Immunotherapy?

Primary Resistance to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

Tumor Microenvironment: Why It Matters for Cancer Immunotherapy

RICE Study: Can Immune Checkpoint Inhibitors Be Used Again After Progression?

Gastrointestinal-Oncology
Claudin 18.2

Claudin 18.2 and FGFR2b: New Biomarkers in Gastric and Esophageal Cancer

FIND Trial: ctDNA-Guided Surveillance After Curative-Intent Colorectal Cancer Surgery

ESMO GI 2026 Hepatobiliary Cancer Highlights: From TACE Combinations to Precision Cholangiocarcinoma Treatment

Liver Cancer: How Dose Distribution Shapes 90Y-SIRT Outcomes

ARISTOTLE Post-Hoc Analysis: AI-Derived Tumour Cell Density in Rectal Cancer

10 Must-Read Posts In GI Oncology This Week

CLARITY-Gastric01: Sonesitatug Vedotin Improves Overall Survival in 2L+ CLDN18.2-Positive Advanced Gastric/GEJ Cancers

Breast-Oncology
TROPION-Breast01

TROPION-Breast01 Details Dato-DXd Safety and Patient-Reported Outcomes

EVERGREEN Study: Everolimus Shows Modest Benefit After CDK4/6 Progression

HER2-Low and HER2-Ultralow: What the Categories Change in Practice

Should Brain MRI Screening Expand in Metastatic Breast Cancer?

Breast Cancer in Gender-Diverse Patients: Younger Age, Frequent Self-Detection, and Favorable Short-Term Survival

RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer

Pregnancy and Recent Childbirth Do Not Independently Worsen Outcomes in Young Women With Early Breast Cancer

Lung-Oncology
BIO 300

Phase 2 Study Evaluates BIO 300 With SBRT in Early-Stage NSCLC and ILD

89 Experts Map Key Gray Zones in Non-Metastatic NSCLC

Molecular Testing Turnaround Before First-Line Therapy in Advanced NSCLC

Ivonescimab Improves Survival After EGFR-TKI Failure

INTEGRAL-Risk May Refine Lung Cancer Screening Eligibility

Early-Stage Lung Cancer Diagnoses Rise Across the United States

Adjuvant Icotinib Linked to Better DFS in Resected Stage IA EGFR-Mutant Lung Adenocarcinoma

Oncology Tech
Personalis

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

The Thirteen-Minute Infusion: What Sarclisa's Wearable Injector Signals for Cancer Care

Kalshi Launches Sportsbook-Style Markets on Drug Trials and FDA Decisions

Hematology
Systemic Mastocytosis Mast Cells

Systemic Mastocytosis: A Hematologic Neoplasm Often Mistaken for Allergy and Other Conditions

Leukemia Diagnosis: Every Step From First Symptoms to Treatment and Beyond

Prognostic Scores and Risk Stratification in Myeloproliferative Neoplasms (MPN): 2026 Updates

Chronic Myelomonocytic Leukemia (CMML): Beyond the Overlap, Toward the Bigger Picture

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

ENDURANCE Trial: 2 Years of Lenalidomide Maintenance Matches Continuous Therapy in Standard-Risk Multiple Myeloma

Peripheral T-Cell Lymphomas (PTCL): Another Evolving Lymphoma Story

Radiotherapy
E2-RADIatE

E2-RADIatE Shows How Prospective Registries Can Strengthen Radiation Oncology Research

IMPulse Trial Tests FLASH Radiotherapy for Melanoma Skin Metastases

Shorter Locoregional Radiotherapy Matches Standard Treatment in High-Risk Breast Cancer

Adaptive MR-Guided SBRT Shows Low Toxicity in Prostate Cancer

10 Must-Read Posts In Radiotherapy This Week: July 20-26

Beyond Mean Dose: Rethinking 90Y-SIRT in HCC

Optimizing Rectal Preparation for Safer Prostate SBRT

OncoDaily TV
World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Elas Sharon, Med News Week

Navigating the Intersection of Immunotherapy and Autoimmunity Dr. Elad Sharon

Rodrigo Sánchez-Bayona open doors

What Makes a Great Oncologist? Insights from Dr. Rodrigo Sánchez-Bayona

Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

ASCO

OncoDaily Highlights from ASCO 2026 Chicago, USA

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Not To Miss
Bladder Cancer

15 Posts Not To Miss From the 2026 Bladder Cancer Advocacy Network Think Tank

Community Oncology Global Congress 2026: Bringing Cancer Care Closer to Where Patients Live

GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg

3rd Symposium “Artificial Intelligence in Public Health Research”

2026 IBRI Global Forum on Science, Philanthropy, and Investment

15 Posts Not To Miss From Best of ASCO Africa 2026

Top Growing Medical Universities in Africa: 2026 Edition by BIGR

OncoGrants
FDA–AACR Oncology

FDA–AACR Oncology Educational Fellowship 2026–2027

Nordic Cancer Union Research

Nordic Cancer Union Research Grants 2026

Assistant Fellowship in Oncology

MD Anderson Postgraduate Physician Assistant Fellowship in Oncology 2027–2028

Victoria’s Secret Global Fund

Victoria’s Secret Global Fund for Women’s Cancers Career Development Award 2026

Postdoctoral Fellowship

CRI Immuno-Informatics Postdoctoral Fellowship 2026–2027

Lobular Carcinoma Research

AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Research Challenge Grants

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Trinanjan Basu

Trinanjan Basu

Oncologists Location Mumbai, India
Nermean Mostafa

Nermean Mostafa

Oncologists Location Cairo, Egypt
Chi-kong Li

Li Chi-kong

Oncologists Location Hong Kong, China
Ilaria Colombo

Ilaria Colombo

Oncologists Location Bellinzona, Switzerland
Matheus de Oliveira Andrade

Matheus de Oliveira Andrade

Oncologists Location Brasília, Brazil
Ilya Tsimafeyeu

Ilya Tsimafeyeu

Oncologists Location Moscow, Russia
Yousef Zakharia

Yousef Zakharia

Oncologists Location Red Wing, USA
Florian Lordick

Florian Lordick

Oncologists Location Leipzig, Germany

Oncology Drugs
DKN-01

DKN-01: Promising DKK1-Targeted Therapy, Dose, Administration, and Clinical Trials

Ponsegromab: Mechanism, Clinical Trials, Presented Data, and Future Role in Cancer Cachexia

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Reviews